• Início
  • Resultados da busca
  • Selective determination of 2,4-xylenol by gas chromatography/supersonic jet/resonance-enhanced multiphoton ionization/time-of-flight mass spectrometry.

Selective determination of 2,4-xylenol by gas chromatography/supersonic jet/resonance-enhanced multiphoton ionization/time-of-flight mass spectrometry.

Analytica chimica acta (2010-11-09)
Hiroko Tsukatani, Hiroki Okudaira, Osamu Shitamichi, Tomohiro Uchimura, Totaro Imasaka
RESUMO

Gas chromatography/supersonic jet/resonance-enhanced multiphoton ionization/time-of-flight mass spectrometry (GC/SSJ/REMPI/TOF-MS) was employed for isomer-selective determination of 2,4-xylenol in river and seawater samples. The sample containing 2,4-xylenol was measured using argon, rather than helium, as the GC carrier gas to cool the analyte molecule sufficiently. The instrumental detection limit (IDL) achieved at a flow rate of 1 mLmin(-1) was 14 pg. Although this value was comparable to the value (ca. 10 pg) obtained by gas chromatography/electron impact/quadrupole mass spectrometry (GC/EI/QMS). When the flow rate was increased to 8 mLmin(-1), interference from the 2,5-xylenol isomer was completely suppressed. The IDL was degraded to 83 or 160 pg at a flow rate of 5 or 8 mLmin(-1), respectively. The recovery of 2,4-xylenol from the river and the seawater samples was 85 and 93%, respectively. The time for analysis was only 10 min per one sample in GC/SSJ/REMPI/TOF-MS. These results suggest that GC/SSJ/REMPI/TOF-MS is useful for the selective measurement of 2,4-xylenol, which has been designated a Class I chemical substance in the Pollutant Release and Transfer Register (PRTR).

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
2,4-Dimethylphenol, 98%
Sigma-Aldrich
2,4-Xylenol, ≥98%

Redes sociais

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Pesquisa. Desenvolvimento. Produção.

Somos um fornecedor global líder para o setor de ciências biológicas, com soluções e serviços para pesquisa, desenvolvimento e produção de biotecnologia, além de produção e desenvolvimento de terapias farmacológicas com medicamentos.

© 2021 Merck KGaA, Darmstadt, Alemanha e/ou suas filiais. Todos os direitos reservados.

A reprodução não autorizada de quaisquer materiais deste site é estritamente proibida.